These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35116978)

  • 1. KIF18A promotes head and neck squamous cell carcinoma invasion and migration via activation of Akt signaling pathway.
    Liu G; Cai G; He X; Huang D; Zhu G; Chen C; Zhang X
    Transl Cancer Res; 2019 Oct; 8(6):2252-2263. PubMed ID: 35116978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DKK3 Overexpression Increases the Malignant Properties of Head and Neck Squamous Cell Carcinoma Cells.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Terada K; Itadani M; Okada N; Hassan NMM; Nagatsuka H; Ikeda T; Nohno T; Fujita S
    Oncol Res; 2018 Jan; 26(1):45-58. PubMed ID: 28470144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced MFAP5 Promotes Tumor Migration and Invasion via AKT Pathway in Head and Neck Squamous Cell Carcinoma.
    Xu Q; Chang H; Tian X; Lou C; Ma H; Yang X
    J Cancer; 2020; 11(6):1596-1605. PubMed ID: 32047565
    [No Abstract]   [Full Text] [Related]  

  • 5. DKK3 knockdown confers negative effects on the malignant potency of head and neck squamous cell carcinoma cells via the PI3K/Akt and MAPK signaling pathways.
    Katase N; Nishimatsu SI; Yamauchi A; Yamamura M; Fujita S
    Int J Oncol; 2019 Mar; 54(3):1021-1032. PubMed ID: 30569110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00460 Promotes Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Head and Neck Squamous Cell Carcinoma via miR-320a/BGN Axis.
    Yang Y; Wang R; Feng L; Ma H; Fang J
    Onco Targets Ther; 2021; 14():2279-2291. PubMed ID: 33833526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-762 Promotes Malignant Development of Head and Neck Squamous Cell Carcinoma by Targeting PHLPP2 and FOXO4.
    Chen S; Zhang JY; Sun LS; Li XF; Bai JY; Zhang HY; Li TJ
    Onco Targets Ther; 2019; 12():11425-11436. PubMed ID: 31920332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-206 inhibits Head and neck squamous cell carcinoma cell progression by targeting HDAC6 via PTEN/AKT/mTOR pathway.
    Liu F; Zhao X; Qian Y; Zhang J; Zhang Y; Yin R
    Biomed Pharmacother; 2017 Dec; 96():229-237. PubMed ID: 28987947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-381 Mediates the Development of Head and Neck Squamous Cell Carcinoma via Targeting STC2.
    Ma HF; Lv GX; Zhang DH
    Onco Targets Ther; 2020; 13():4485-4493. PubMed ID: 32547079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.
    Chen X; Zhang S; Liu C; Li G; Lu S; Wang Y; Zhang X; Huang D; Qiu Y; Liu Y
    Onco Targets Ther; 2020; 13():6191-6202. PubMed ID: 32636643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the Wnt/β-Catenin signaling pathway in the heterogenous nuclear ribonucleoprotein K-driven inhibition of proliferation and migration in head and neck squamous cell carcinoma.
    Liu H; Chen X; Yang X; Li M; Zhang W; Zhang G; Zhan X; Cao L; Li W; Huang Z; Gao R
    Oncol Lett; 2020 Dec; 20(6):394. PubMed ID: 33193854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro.
    Abhold E; Rahimy E; Wang-Rodriguez J; Blair KJ; Yu MA; Brumund KT; Weisman RA; Ongkeko WM
    BMC Res Notes; 2011 Dec; 4():553. PubMed ID: 22188703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-1 drives perineural invasion via PI3K-AKT signaling pathway in head and neck squamous cancer.
    Wang J; Li Q; Liang F; Du X; Song P; Wu T; Chen R; Lin X; Liu Q; Hu H; Han P; Huang X
    MedComm (2020); 2024 Apr; 5(4):e518. PubMed ID: 38525111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Overexpression of Fibronectin 1 Promotes Cancer Progression and Associated with M2 Macrophages Polarization in Head and Neck Squamous Cell Carcinoma Patients.
    Zhou WH; Du WD; Li YF; Al-Aroomi MA; Yan C; Wang Y; Zhang ZY; Liu FY; Sun CF
    Int J Gen Med; 2022; 15():5027-5042. PubMed ID: 35607361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

  • 18. Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.
    Cameron S; de Long LM; Hazar-Rethinam M; Topkas E; Endo-Munoz L; Cumming A; Gannon O; Guminski A; Saunders N
    Mol Cancer; 2012 Sep; 11():74. PubMed ID: 23021083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of anti-DKK3 peptide for the cancer control in head and neck squamous cell carcinoma (HNSCC).
    Katase N; Nishimatsu SI; Yamauchi A; Okano S; Fujita S
    Cancer Cell Int; 2022 Nov; 22(1):352. PubMed ID: 36376957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.